Hindustan Unilever, Piramal Pharma and DJ Mediaprint & Logistics to see some action today

23 Jan 2025 Evaluate

Hindustan Unilever has signed and executed the Share Purchase and Subscription Agreement (SPSA) for acquisition of 90.5% of shareholding of Uprising Science (Uprising) comprising secondary buyout for a cash consideration of Rs 2670 crore at a pre-money Enterprise Valuation of Rs 2955 crore (subject to adjustments as set out in the SPSA) and a primary infusion of Rs 45 crore, with an eventual acquisition of the remaining 9.5% of Uprising’s shareholding as per the terms set out therein (Proposed Acquisition). The acquisition is another step in the transformation journey of the Company’s Beauty & Wellbeing portfolio towards evolving and higher growth demand spaces.

Piramal Pharma’s division -- Piramal Critical Care (PCC) has announced the U.S. launch of Chlorpromazine Hydrochloride for Injection, USP, which will be offered in 25mg/1mL and 50mg/2 mL vials. With this launch, PCC continues to expand their generic injectables portfolio. The launch of Chlorpromazine Hydrochloride for Injection, USP (25mg/1mL and 50mg/2 mL vials) is the latest in a series of recent product launches from Piramal Critical Care in the generic injectables market.

DJ Mediaprint & Logistics has acquired 51% stake in Sai Links, a Partnership firm on January 22, 2025. This acquisition marks a significant strategic move, presenting an absorbing opportunity to expand into the mobility services segment, aligning with the company's growth objectives.

Coforge has agreed to enter into a Stock Purchase Agreement with Xceltrait Inc. and its stockholders (Stock Purchase Agreement) to acquire all of the outstanding shares of capital stock of Xceltrait Inc. (Proposed Transaction) and completion of closing conditions and closing deliveries as per the Stock Purchase Agreement. With the consummation of the Proposed Transaction, the group will be able to leverage the abovementioned capabilities and expand across various Coforge accounts.

Bharat Petroleum Corporation (BPCL) has reported 19.63% rise in its consolidated net profit at Rs 3805.94 crore for third quarter ended December 31, 2024 (Q3FY25) as compared to Rs 3181.42 crore for the same quarter in the previous year. However, total income of the company decreased by 1.78% at Rs 128158.36 crore for Q3FY25 as compared to Rs 130475.59 crore for the corresponding quarter previous year.

RPP Infra Projects has been received letter of acceptance for a new projects - Erection, Testing & Commissioning of Air Cooled Condenser (ACC) and associated auxiliaries of Unit 2 at 3x800 MW PVUNL STPP Patratu Jharkhand for Contract Value of Rs 28.77 crore (Inc GST).

Waaree Energies’ wholly owned subsidiary -- Waaree Solar Americas Inc. has started its commercial production of 1.6 GW Solar Module line at its Unit situated at Brookshire, in the state of Texas, USA.

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.